Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Net Margin (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Net Margin data on record, last reported at 1.58% in Q4 2025.

  • For Q4 2025, Net Margin fell 382.0% year-over-year to 1.58%; the TTM value through Oct 2025 reached 4.16%, up 528.0%, while the annual FY2025 figure was 8.26%, 2276.0% up from the prior year.
  • Net Margin reached 1.58% in Q4 2025 per CSBR's latest filing, up from 3.33% in the prior quarter.
  • Across five years, Net Margin topped out at 26.38% in Q1 2025 and bottomed at 21.05% in Q1 2024.
  • Average Net Margin over 5 years is 3.4%, with a median of 1.92% recorded in 2022.
  • Peak YoY movement for Net Margin: crashed -2506bps in 2023, then surged 4743bps in 2025.
  • A 5-year view of Net Margin shows it stood at 2.35% in 2021, then tumbled by -105bps to 0.11% in 2022, then tumbled by -15872bps to 17.9% in 2023, then skyrocketed by 130bps to 5.4% in 2024, then crashed by -71bps to 1.58% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 1.58% in Q4 2025, 3.33% in Q3 2025, and 14.85% in Q2 2025.